Trials / Completed
CompletedNCT05829421
Addressing Problems in Managing Daily Tasks Due to Poststroke Cognitive Impairments
Feasibility of a Neuropsychologically Informed Occupational Therapy Intervention Targeting Decreased Ability to Perform Activities of Daily Living in People With Poststroke Cognitive Impairment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Emma Ghaziani · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate feasibility aspects of an intervention targeting problems in managing daily tasks due to mild-to-moderate poststroke cognitive impairments. We will specifically address uncertainties related to intervention content and delivery, and trial design and conduct.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Impairment-specific occupational therapy (OT) intervention | In parallel with standard practice, patients receive an OT intervention adapted to the specific underlying cognitive impairments that are likely to disturb their performance of ADLs. The intervention is individualised through a 3-step process: a) a list of dysfunctional ADL process skills is forwarded by the OT to the neuropsychologist (NP), b) the NP identifies the cognitive impairments which are most likely to cause the dysfunctional ADL process skills through a cognitive assessment, c) based on the identified cognitive impairments, the NP and the OT select in collaboration the cognitive strategies that are most likely to benefit the individual patient from a pre-prepared intervention manual. Because of the large heterogeneity in how cognitive impairments impact on ADL performance, the exact way of implementing the selected cognitive strategies into the practice of the individual patient is left to the OT´s clinical judgement. |
Timeline
- Start date
- 2023-05-25
- Primary completion
- 2024-03-29
- Completion
- 2025-10-01
- First posted
- 2023-04-25
- Last updated
- 2025-12-05
Locations
4 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05829421. Inclusion in this directory is not an endorsement.